Explore stories from Atlantic Canada.
- A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.
In 2019, some manufacturers and pharmacies halted Zantac sales after a chemical called NDMA, which is known to cause cancer, was detected in some pills. Some tests showed that Zantac's active ingredient, ranitidine, could degrade into NDMA over time or when exposed to heat. Medinilla is presiding over the majority of nearly 80,000 cases still pending in the United States over Zantac, which was once the world's top-selling drug.
The drugmakers notched a significant win in 2022, when another judge dismissed about 50,000 lawsuits making similar claims that had been consolidated in federal court in Florida.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer agrees to settle more than 10,000 Zantac lawsuits in U.S.: Bloomberg NewsPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Read more »
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg NewsPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Read more »
Pfizer Agrees to Settle More than 10,000 Zantac Cancer LawsuitsPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.
Read more »
GSK Faces Whistleblower Suit From Lab That Found Zantac RiskGSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the heartburn medication that the UK drugmaker invented and turned into a blockbuster.
Read more »
First Zantac Cancer Case to Go to Trial Ends in Win for DrugmakersDrugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in the first of thousands of such lawsuits to go to trial.
Read more »
Judge assured that Tesla won't contest Musk pay ruling outside DelawareThe Delaware judge who voided Elon Musk's record Tesla pay package told the parties in the case that she felt assured by the electric vehicle maker that it...
Read more »